Does selective binding profile result in 'selective treatment'?

Japanese Journal of Psychopharmacology

Volumn 21, Issue 1, 2001, Pages 1-5

  Suzuki, T ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Antipsychotics; MARTA; Olazapine; Receptor selectivity; SDA

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; CLOZAPINE; DOPAMINE RECEPTOR BLOCKING AGENT; GLUTAMIC ACID; MUSCARINIC RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN ANTAGONIST;

ANXIETY NEUROSIS; ARTICLE; BINDING AFFINITY; COGNITIVE DEFECT; DEPRESSION; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; HUMANS; RECEPTORS, DOPAMINE D2; RECEPTORS, DRUG; RECEPTORS, SEROTONIN;

EID: 0034983580     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response
2. Reversal of isolation rearing-induced deficits in prepulse inhibition by seroquel and olanzapine
3. Effect of drug influencing central serotonergic mechanisms on haloperidol-induced catalepsy
4. Radioreceptor binding profile of the atypical antipsychotic olanzapine
5. Schizophrenia : A subcortical neurotransmitter imbalance syndrome?
6. A glutamatergic deficiency model of schizophrenia
7. Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors
8. The glutamate synapse in neuropsychiatric disorders
9. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor selective antagonists in mice
10. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release
11. Serotonin (2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat
12. Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area
13. Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum
14. 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo
15. The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent
16. Decreased prefrontal DA D1 receptors in schizophrenia revealed by PET
17. Glutamate receptor dysfunction and schizophrenia
18. The role of D1-dopamine receptor in working memory: Local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task
19. Olanzapine, a novel atypical antipsychotic, reverses d-amphetamine-induced inhibition of midbrain dopamine cells
20. Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: Role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism
21. Schizophrenia and glutamatergic transmission
22. Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition
23. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocipline-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats
24. Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats